Objective: To assess the prevalence of anti-Ro/SSA in RA and to analyse clinical and serological features of anti-Ro/SSA positive patients with RA. Methods: 195 consecutive patients affected by RA were studied by counterimmunoelectrophoresis and ELISA for the detection of anti-Ro/SSA antibodies. Anti-Ro were found in 12 patients, with a prevalence of 6%. These 12 patients were pooled with other 15 patients known to have anti-Ro/SSA antibodies and RA, in order to evaluate their clinical and laboratory features. Results: Anti-Ro positive patients showed a common pattern of joint involvement at onset and a comparable progression of disease compared to anti-Ro negative subjects. In addition, extra-articular manifestations (such as xerophthalmia, xerostomia, scleritis, oral ulcers and amyloidosis) and peculiar autoantibody profile (hypergammaglobulinemia, anti-dsDNA and AMA) were found significantly associated to anti-Ro/SSA positivity. Even though DMARDs withdrawals were more frequently detected in anti-Ro/SSA patients, especially when using gold salts, no statistical difference between the two groups was detected. In addition, anti-TNFα treatment did not cause further progression of autoimmunity neither on laboratory nor on clinical ground. Conclusion: Anti-Ro/SSA can be detected in about 6% of patients affected by RA. These patients presented a peculiar clinical picture characterised by extra-articular manifestations some of which are known to be anti-Ro/SSA correlated, while others are more disease-specific (amyloidosis, episcleritis). Anti-Ro/SSA are significantly associated with other autoantibodies not specific for RA such as anti-dsDNA and AMA. Treatment with anti-TNF drugs did not cause further progression of autoimmunity neither on laboratory nor on clinical ground

Cavazzana, I., Franceschini, F., Quinzanini, M., Manera, C., Del Papa, N., Maglione, W., et al. (2006). Anti-Ro/SSA antibodies in rheumatoid arthritis: Clinical and immunologic associations. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 24(1), 59-64.

Anti-Ro/SSA antibodies in rheumatoid arthritis: Clinical and immunologic associations

SINICO, RENATO ALBERTO;
2006

Abstract

Objective: To assess the prevalence of anti-Ro/SSA in RA and to analyse clinical and serological features of anti-Ro/SSA positive patients with RA. Methods: 195 consecutive patients affected by RA were studied by counterimmunoelectrophoresis and ELISA for the detection of anti-Ro/SSA antibodies. Anti-Ro were found in 12 patients, with a prevalence of 6%. These 12 patients were pooled with other 15 patients known to have anti-Ro/SSA antibodies and RA, in order to evaluate their clinical and laboratory features. Results: Anti-Ro positive patients showed a common pattern of joint involvement at onset and a comparable progression of disease compared to anti-Ro negative subjects. In addition, extra-articular manifestations (such as xerophthalmia, xerostomia, scleritis, oral ulcers and amyloidosis) and peculiar autoantibody profile (hypergammaglobulinemia, anti-dsDNA and AMA) were found significantly associated to anti-Ro/SSA positivity. Even though DMARDs withdrawals were more frequently detected in anti-Ro/SSA patients, especially when using gold salts, no statistical difference between the two groups was detected. In addition, anti-TNFα treatment did not cause further progression of autoimmunity neither on laboratory nor on clinical ground. Conclusion: Anti-Ro/SSA can be detected in about 6% of patients affected by RA. These patients presented a peculiar clinical picture characterised by extra-articular manifestations some of which are known to be anti-Ro/SSA correlated, while others are more disease-specific (amyloidosis, episcleritis). Anti-Ro/SSA are significantly associated with other autoantibodies not specific for RA such as anti-dsDNA and AMA. Treatment with anti-TNF drugs did not cause further progression of autoimmunity neither on laboratory nor on clinical ground
Articolo in rivista - Articolo scientifico
Amyloidosis; Antibodies, Antinuclear; Arthritis, Rheumatoid; Autoantibodies; Counterimmunoelectrophoresis; Enzyme-Linked Immunosorbent Assay; Eye Diseases; Female; Humans; Hypergammaglobulinemia; Male; Middle Aged; Mitochondria; Oral Ulcer; Scleritis; Xerophthalmia
English
59
64
6
Cavazzana, I., Franceschini, F., Quinzanini, M., Manera, C., Del Papa, N., Maglione, W., et al. (2006). Anti-Ro/SSA antibodies in rheumatoid arthritis: Clinical and immunologic associations. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 24(1), 59-64.
Cavazzana, I; Franceschini, F; Quinzanini, M; Manera, C; Del Papa, N; Maglione, W; Comina, D; Radice, A; Sinico, R; Cattaneo, R
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/139396
Citazioni
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 25
Social impact